OMX Stockholm 30
2.670,54
PKT
+8,22
PKT
+0,31
%
Werbung
Analysen zu OMX Stockholm 30-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 27.11.24 | Volvo (B) Overweight | JP Morgan Chase & Co. | |
| 26.11.24 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 26.11.24 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 26.11.24 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 25.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 25.11.24 | Hennes Mauritz (H M, H&M) Buy | Deutsche Bank AG | |
| 20.11.24 | Volvo (B) Buy | Jefferies & Company Inc. | |
| 20.11.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.11.24 | AstraZeneca Neutral | UBS AG | |
| 19.11.24 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 19.11.24 | Volvo (B) Neutral | UBS AG | |
| 15.11.24 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 13.11.24 | AstraZeneca Halten | DZ BANK | |
| 13.11.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 13.11.24 | Hennes Mauritz (H M, H&M) Buy | UBS AG | |
| 13.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 12.11.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 12.11.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 12.11.24 | AstraZeneca Sell | UBS AG | |
| 12.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 12.11.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 08.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 07.11.24 | AstraZeneca Sell | UBS AG | |
| 06.11.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 06.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 05.11.24 | AstraZeneca Sell | UBS AG | |
| 05.11.24 | AstraZeneca Sell | Deutsche Bank AG | |
| 05.11.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.11.24 | Hennes Mauritz (H M, H&M) Outperform | RBC Capital Markets | |
| 05.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 05.11.24 | AstraZeneca Sell | UBS AG | |
| 04.11.24 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 04.11.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 29.10.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 29.10.24 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 28.10.24 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 25.10.24 | Volvo (B) Neutral | UBS AG | |
| 25.10.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 25.10.24 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 22.10.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.